WVP
INSM icon

Worth Venture Partners’s Insmed INSM Stock Holding History

Worth Venture Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,400
Closed -$597K – 71
2024
Q1 		$418K Buy
+15,400
New +$431K 2.78% 10
2017
Q4 		– Sell
-30,454
Closed -$950K – 123
2017
Q3 		$950K Buy
30,454
+18,119
+147% +$345K 0.82% 24
2017
Q2 		$212K Buy
12,335
+11,232
+1,018% +$192K 0.18% 83
2017
Q1 		$19K Buy
+1,103
New +$17K 0.02% 121

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Worth Venture Partners's INSM Position: Q2 2024 in Review

Worth Venture Partners sold out of Insmed (INSM) in Q2 2024, closing a stake of 15,400 shares — an estimated $597K sold.

Worth Venture Partners first reported a position in INSM in Q1 2017 and held it in 4 quarters. The position peaked at $950K in Q3 2017. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

  • Worth Venture Partners reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
  • Worth Venture Partners sold 15,400 Insmed shares in Q2 2024, an estimated $597K.
  • Worth Venture Partners first reported a position in Insmed in Q1 2017 and held it in 4 quarters.
  • Worth Venture Partners's Insmed position peaked at $950K in Q3 2017.
  • 378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.